Display options
Cite
Yalçin F, Yalçin H, Abraham MR, et al. Ultimate phases of hypertensive heart disease and stressed heart morphology by conventional and novel cardiac imaging. Am J Cardiovasc Dis. 2021;11(5):628-634
Yalçin, F., Yalçin, H., Abraham, M. R., & Abraham, T. P. (2021). Ultimate phases of hypertensive heart disease and stressed heart morphology by conventional and novel cardiac imaging. American journal of cardiovascular disease, 11(5), 628-634.
Yalçin, Fatih, et al. "Ultimate phases of hypertensive heart disease and stressed heart morphology by conventional and novel cardiac imaging." American journal of cardiovascular disease vol. 11,5 (2021): 628-634.
Yalçin F, Yalçin H, Abraham MR, Abraham TP. Ultimate phases of hypertensive heart disease and stressed heart morphology by conventional and novel cardiac imaging. Am J Cardiovasc Dis. 2021 Oct 25;11(5):628-634. eCollection 2021. PMID: 34849295; PMCID: PMC8611267.
Copy Download .nbib Format: NLM
Share it on

Am J Cardiovasc Dis. 2021 Oct 25;11(5):628-634. eCollection 2021.

Ultimate phases of hypertensive heart disease and stressed heart morphology by conventional and novel cardiac imaging.

American journal of cardiovascular disease

Fatih Yalçin, Hulya Yalçin, Maria Roselle Abraham, Theodore P Abraham

Affiliations

  1. Department of Medicine, Cardiology UCSF Health, University of California San Francisco, CA, USA.

PMID: 34849295 PMCID: PMC8611267

Abstract

Early recognition of hypertensive heart disease is needed to prevent macrovascular and microvascular damage. Hypertension (HTN) is a risk factor for coronary artery disease, and plays a prominent role in the development of adverse left ventricular (LV) remodeling and heart failure. Here, we review new knowledge on effects of HTN on cardiac geometry and function, obtained from multimodality cardiac imaging, including echocardiography, positron emission tomography and magnetic resonance imaging. Early recognition of changes in LV geometry and function induced by HTN could identify patients at risk for end-organ damage, who could be targeted for close monitoring and intensive therapy. Basal septal hypertrophy as the early imaging biomarker at the adaptive phase may be a specific aspect not only in hypertensive heart but stress-related conditions and called stressed heart morphology.

AJCD Copyright © 2021.

Keywords: Hypertension; adaptive phase; basal septal hypertrophy; echocardiography; stressed heart morphology

Conflict of interest statement

None.

References

  1. Circulation. 2003 Aug 5;108(5):560-5 - PubMed
  2. Circulation. 2000 Jan 25;101(3):258-63 - PubMed
  3. Heart. 2010 Jun;96(12):948-55 - PubMed
  4. Int J Cardiol. 1988 Feb;18(2):207-21 - PubMed
  5. J Hypertens. 2006 Apr;24(4):767-73 - PubMed
  6. J Am Coll Cardiol. 2005 Oct 4;46(7):1270-5 - PubMed
  7. Circulation. 1977 Jun;55(6):901-8 - PubMed
  8. Blood Press Monit. 2020 Apr;25(2):118-119 - PubMed
  9. Blood Press Monit. 2019 Jun;24(3):110-113 - PubMed
  10. Eur J Echocardiogr. 2008 Jul;9(4):501-8 - PubMed
  11. Int J Cardiol. 2009 Jun 26;135(2):251-2 - PubMed
  12. J Hypertens. 2010 Jul;28(7):1541-6 - PubMed
  13. Int J Cardiol Heart Vasc. 2015 Apr 08;7:141-145 - PubMed
  14. Ann Thorac Cardiovasc Surg. 2021 Oct 20;27(5):332-334 - PubMed
  15. J Hum Hypertens. 2011 Oct;25(10):578-84 - PubMed
  16. Am J Hypertens. 1995 Oct;8(10 Pt 1):1040-5 - PubMed
  17. Heart Vessels. 2003 Mar;18(1):32-9 - PubMed
  18. Am Heart J. 1988 Feb;115(2):385-90 - PubMed
  19. Int J Cardiol. 2002 Dec;86(2-3):199-205 - PubMed
  20. J Am Soc Echocardiogr. 2010 Mar;23(3):240-57; 335-7 - PubMed
  21. J Am Soc Echocardiogr. 1997 Jun;10(5):545-55 - PubMed
  22. Ann Intern Med. 1990 Feb 1;112(3):161-6 - PubMed
  23. Circulation. 1993 Sep;88(3):993-1003 - PubMed
  24. Hypertension. 1997 Oct;30(4):777-81 - PubMed
  25. Hypertension. 1988 May;11(5):457-63 - PubMed
  26. Circulation. 2005 Feb 1;111(4):472-9 - PubMed
  27. Am J Cardiol. 1998 Jun 1;81(11):1318-22 - PubMed
  28. Circulation. 1996 Jan 15;93(2):259-65 - PubMed
  29. Int J Cardiol Heart Vasc. 2015 Jan 09;9:43-47 - PubMed
  30. Int J Cardiol. 2010 Nov 19;145(2):367-368 - PubMed
  31. Circ Cardiovasc Imaging. 2013 Mar 1;6(2):262-7 - PubMed
  32. J Am Soc Echocardiogr. 2001 May;14(5):370-7 - PubMed
  33. Echocardiography. 2008 Apr;25(4):424-8 - PubMed
  34. JACC Cardiovasc Imaging. 2015 Feb;8(2):172-80 - PubMed
  35. Circ Heart Fail. 2009 Jul;2(4):303-10 - PubMed
  36. Circ Res. 2017 Sep 15;121(7):874-891 - PubMed
  37. Am J Cardiol. 2001 Mar 15;87(6):732-6 - PubMed
  38. J Hypertens. 2008 Apr;26(4):806-12 - PubMed
  39. Circ Cardiovasc Imaging. 2009 Sep;2(5):382-90 - PubMed
  40. Am J Cardiol. 2008 Sep 1;102(5):616-20 - PubMed
  41. J Hypertens. 1999 May;17(5):685-93 - PubMed
  42. Circ Res. 1965 Jan;16:39-44 - PubMed
  43. J Am Soc Echocardiogr. 2004 Jul;17(7):717-22 - PubMed
  44. Int J Cardiol Heart Vasc. 2015 Apr 09;7:149-150 - PubMed
  45. J Appl Physiol (1985). 2019 Feb 1;126(2):354-362 - PubMed
  46. Circulation. 1993 Oct;88(4 Pt 1):1444-55 - PubMed
  47. Am J Cardiol. 2000 Apr 15;85(8):1035-8 - PubMed
  48. N Engl J Med. 2006 Apr 20;354(16):1685-97 - PubMed
  49. J Hum Hypertens. 2006 Aug;20(8):628-30 - PubMed
  50. Circulation. 2001 Jul 17;104(3):286-91 - PubMed
  51. Angiology. 2004 May-Jun;55(3):295-301 - PubMed
  52. Circulation. 1977 Jan;55(1):153-7 - PubMed
  53. Circ Cardiovasc Imaging. 2013 Sep;6(5):e28 - PubMed
  54. JACC Cardiovasc Imaging. 2015 Feb;8(2):181-3 - PubMed
  55. Hypertension. 2000 Feb;35(2):580-6 - PubMed
  56. Int J Cardiol. 2010 Aug 6;143(1):e1-3 - PubMed
  57. Eur J Prev Cardiol. 2014 Aug;21(8):980-8 - PubMed
  58. Metabolism. 2008 Oct;57 Suppl 2:S36-9 - PubMed
  59. Echocardiography. 2003 Aug;20(6):563-6 - PubMed
  60. Circulation. 1998 Aug 11;98(6):535-40 - PubMed
  61. Cardiovasc Ultrasound. 2011 Aug 16;9:22 - PubMed

Publication Types